HUY D LAM

Allopathic & Osteopathic Physicians|Family Medicine WESTMINSTER, CA NPI 1992148530

General Payments — all program years on this page

$2,262.54

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 121
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $516.43 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $516.4320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $58.624
2019 $176.5910
2020 $322.6619
2021 $405.2323
2022 $453.6431
2023 $329.3714
2024 $516.4320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086259420 Bayer Healthcare Pharmaceuticals Inc. $19.03 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096583002 Novo Nordisk Inc $17.30 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096605619 Novo Nordisk Inc $13.84 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096732855 Novo Nordisk Inc $16.42 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097201104 Novo Nordisk Inc $17.11 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104400047 AstraZeneca Pharmaceuticals LP $18.41 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105229229 AstraZeneca Pharmaceuticals LP $18.95 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105349690 AstraZeneca Pharmaceuticals LP $17.73 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105361169 AstraZeneca Pharmaceuticals LP $18.89 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111627594 Amgen Inc. $29.28 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111627596 Amgen Inc. $24.58 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117304468 Amgen Inc. $18.49 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133748472 Gilead Sciences, Inc. $26.72 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135024996 Lilly USA, LLC $26.70 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141875056 Merck Sharp & Dohme LLC $20.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141934309 Merck Sharp & Dohme LLC $14.36 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146992040 AIMMUNE THERAPEUTICS, INC. $19.09 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151086145 Phathom Pharmaceuticals, Inc. $17.41 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151086147 Phathom Pharmaceuticals, Inc. $17.81 08/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154802257 HISTOSONICS,INC. $144.31 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.